| Previous Close | 57.67 |
| Open | 57.63 |
| Bid | 57.47 x 200 |
| Ask | 58.00 x 500 |
| Day's Range | 57.43 - 58.17 |
| 52 Week Range | 46.01 - 60.45 |
| Volume | 4,017,429 |
| Avg. Volume | 7,251,301 |
| Market Cap | 94.9B |
| Beta | 1.04 |
| PE Ratio (TTM) | 20.10 |
| EPS (TTM) | 2.88 |
| Earnings Date | Oct 25, 2017 - Oct 30, 2017 |
| Dividend & Yield | 1.56 (2.75%) |
| Ex-Dividend Date | 2017-07-05 |
| 1y Target Est | 57.73 |
- Market Realist•8 hours ago
Incyte Had These Key Collaborations and Developments in 2Q17
Incyte (INCY) distributes its key drug, Jakafi, through its own network of specialty pharmacy providers and wholesalers in US markets.
- Motley Fool•yesterday
What's Next for Bristol-Myers Squibb After Its Opdivo Setback?
Mixed results for a study with Opdivo in treating first-line kidney cancer give reasons for concern. But how worried should investors really be?
Markit•yesterdaySee what the IHS Markit Score report has to say about Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co NYSE:BMY
